Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1951 to 2000 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1951\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRIT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
trna isopentenylpyrophosphate transferase. [source:refseq;acc:nm\_017646]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.876\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.873\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00982\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1952\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KPNA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
importin alpha-1 subunit (karyopherin alpha-1 subunit) (srp1-beta) (rag cohort protein 2) (nucleoprotein interactor 1) (npi-1). [source:swissprot;acc:p52294]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.647\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.724\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00981\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1953\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPP1R2P9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
type 1 protein phosphatase inhibitor. [source:refseq;acc:nm\_025210]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
125.912\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
127.146\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0098\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1954\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNAB3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-3 subunit (k+ channel beta-3 subunit) (kv-beta-3). [source:swissprot;acc:o43448]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.632\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.703\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00979\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1955\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YIF1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
yip1 interacting factor homolog; yip1p-interacting factor; putative rab5-interacting protein; putative transmembrane protein 54tmp. [source:refseq;acc:nm\_020470]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.633\vspace{3pt}}}&&\multirow{15}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00978\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1956\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNAB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-1 subunit (k+ channel beta-1 subunit) (kv-beta-1). [source:swissprot;acc:q14722]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1957\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YIF1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to putative transmembrane protein; homolog of yeast golgi membrane protein yif1p (yip1p-interacting factor). [source:refseq;acc:nm\_033557]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1958\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AKR7A3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 2 (ec 1.-.-.-) (afb1-ar 2). [source:swissprot;acc:o95154]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1959\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ABHD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha/beta hydrolase domain containing protein 3; lung alpha/beta hydrolase 3. [source:refseq;acc:nm\_138340]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1960\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YIPF5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
golgi membrane protein sb140; smooth muscle cell associated protein 5. [source:refseq;acc:nm\_030799]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1961\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ABHD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha/beta hydrolase domain containing protein 1 isoform 2; lung alpha/beta hydrolase protein 1. [source:refseq;acc:nm\_152870]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1962\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALDH6A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial precursor (ec 1.2.1.27) (mmsdh). [source:swissprot;acc:q02252]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.702\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1963\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HSPE1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10 kda heat shock protein, mitochondrial (hsp10) (10 kda chaperonin) (cpn10). [source:swissprot;acc:q04984]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.633\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.703\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1964\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RABAC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rab acceptor 1 (prenylated); prenylated rab acceptor 1. [source:refseq;acc:nm\_006423]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1965\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha adducin (erythrocyte adducin alpha subunit). [source:swissprot;acc:p35611]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.258\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1966\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
REXO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
oligoribonuclease, mitochondrial precursor (ec 3.1.-.-) (small fragment nuclease) (cgi-114). [source:swissprot;acc:q9y3b8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.633\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.703\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1967\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHAT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
choline o-acetyltransferase (ec 2.3.1.6) (choactase) (choline acetylase) (chat). [source:swissprot;acc:p28329]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.702\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1968\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNAB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-2 subunit (k+ channel beta-2 subunit) (kv-beta-2) (hkvbeta2). [source:swissprot;acc:q13303]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.633\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.703\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1969\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AKR7A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 1 (ec 1.-.-.-) (afb1-ar 1) (aldoketoreductase 7). [source:swissprot;acc:o43488]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1970\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KPNA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
importin alpha-6 subunit (karyopherin alpha-5 subunit). [source:swissprot;acc:o15131]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.683\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00975\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1971\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CKM\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
creatine kinase, m chain (ec 2.7.3.2) (m-ck). [source:swissprot;acc:p06732]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.258\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
196.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00974\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1972\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEC16B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
regucalcin gene promotor region related protein; rgpr-p117. [source:refseq;acc:nm\_033127]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.777\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.659\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00973\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1973\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein family member 2 (wasp-family protein member 2) (verprolin homology domain-containing protein 2). [source:swissprot;acc:q9y6w5]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.611\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
212.546\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00972\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1974\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WASF3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein family member 3 (wasp-family protein member 3) (verprolin homology domain-containing protein 3). [source:swissprot;acc:q9upy6]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1975\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WASF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein family member 1 (wasp-family protein member 1) (verprolin homology domain-containing protein 1). [source:swissprot;acc:q92558]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1976\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RCOR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rest corepressor. [source:refseq;acc:nm\_015156]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1977\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homolog of yeast maf1. [source:refseq;acc:nm\_032272]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
209.539\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
207.529\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00969\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1978\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tumor differentially expressed protein 2. [source:refseq;acc:nm\_178865]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1979\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tumor differentially expressed protein 1 (transmembrane protein sbbi99). [source:swissprot;acc:q13530]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1980\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tumor differentially expressed 1 protein like. [source:swissprot;acc:q9nrx5]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1981\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHGDH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
d-3-phosphoglycerate dehydrogenase (ec 1.1.1.95) (3-pgdh). [source:swissprot;acc:o43175]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1982\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s28. [source:swissprot;acc:p25112]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.343\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198.427\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00966\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1983\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDLIM5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim protein (similar to rat protein kinase c-binding enigma); enigma homolog. [source:refseq;acc:nm\_006457]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.175\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00955\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1984\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EP400\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
e1a binding protein p400; p400 swi2/snf2-related protein; cagh32 protein; trinucleotide repeat containing 12. [source:refseq;acc:nm\_015409]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.26\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.193\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00952\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1985\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPL24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l24. [source:refseq;acc:nm\_024540]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1986\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YAP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
65 kda yes-associated protein (yap65). [source:swissprot;acc:p46937]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1987\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIN7A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lin-7 homolog a; vertebrate lin7 homolog 1; tax interaction protein 33; mammalian lin-7 1. [source:refseq;acc:nm\_004664]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.022\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.9\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1988\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CCDC130\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9 kda protein. [source:swissprot;acc:p13994]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.193\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1989\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COL4A3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
collagen alpha 3(iv) chain precursor (goodpasture antigen). [source:swissprot;acc:q01955]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.261\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.195\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00951\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1990\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
collagen alpha 5(iv) chain precursor. [source:swissprot;acc:p29400]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.26\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.194\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1991\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WWTR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcriptional co-activator with pdz-binding motif (taz). [source:refseq;acc:nm\_015472]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1992\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LDB3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zasp protein (fragment). [source:sptrembl;acc:q9y4z3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.267\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.207\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00948\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1993\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIP1R\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
huntingtin interacting protein 1 related (hip1-related) (hip 12). [source:swissprot;acc:o75146]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
189.052\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.835\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00943\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1994\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COL4A3BP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
goodpasture antigen-binding protein (ec 2.7.1.37) (gpbp) (collagen type iv alpha 3 binding protein) (star-related lipid transfer protein 11) (stard11) (start domain-containing protein 11). [source:swissprot;acc:q9y5p4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
189.011\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.787\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1995\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
huntingtin interacting protein 1 (hip-i). [source:swissprot;acc:o00291]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.961\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.73\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00936\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1996\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC5A5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sodium/iodide cotransporter (na(+)/i(-) cotransporter) (sodium-iodide symporter) (na+/i-symporter). [source:swissprot;acc:q92911]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.682\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.784\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1997\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRODH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kidney and liver proline oxidase 1. [source:refseq;acc:nm\_021232]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.651\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.759\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00933\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1998\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C15orf15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ribosomal protein l24-like; 60s ribosomal protein l30 isolog; my024 protein; homolog of yeast ribosomal like protein 24. [source:refseq;acc:nm\_016304]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.219\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00932\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1999\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC5A8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 5 (iodide transporter), member 8; apical iodide transporter. [source:refseq;acc:nm\_145913]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.636\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.748\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00931\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2000\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC5A6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sodium-dependent multivitamin transporter (na(+)-dependent multivitamin transporter). [source:swissprot;acc:q9y289]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.626\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.739\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/